The future of cancer diagnosis and treatment will be based on personalized, genomic medicine. Knowing what genomic alterations underlie a patient’s cancer allows the use of therapies that will kill tumor cells and leave the patient unharmed. GenomOncology offers proprietary software and analytical tools that rapidly and interactively analyze and interpret sequenced genomic data. The company’s approach enables the capture of critical findings for the cancer researcher or clinical oncologist and the production of a robust analysis report in less than a day.